The company is hoping longer follow-up will deliver enough positive trial data on its CRISPR T-cell therapies for blood ...

Bristol Myers Squibb’s new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of ...

We expect investors to focus on the sales numbers of CRISPR Therapeutics’ CRSP sole-marketed product, Casgevy, and other ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

Biomedical Research leads at USD 1.5 billion, supporting genetic discovery and translational research.